Evommune, Inc. (EVMN) SEC Filings https://ir.evommune.com/financial-information/sec-filings/rss Evommune, Inc. (EVMN) - SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_2094dba4d31887f5c3cda4773c265127/evommune/files/theme/images/logo-sm.png Evommune, Inc. Logo Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001620548-26-000009/0001620548-26-000009.pdf Thu, 15 Oct 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001620548-26-000009/0001620548-26-000009.pdf <![CDATA[8-K - Current report]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-409865/0001193125-26-409865.pdf Thu, 01 Oct 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-409865/0001193125-26-409865.pdf <![CDATA[8-K - Current report]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-399378/0001193125-26-399378.pdf Wed, 23 Sep 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-399378/0001193125-26-399378.pdf <![CDATA[8-K - Current report]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-391390/0001193125-26-391390.pdf Tue, 15 Sep 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-391390/0001193125-26-391390.pdf <![CDATA[8-K - Current report]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-385430/0001193125-26-385430.pdf Wed, 09 Sep 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-385430/0001193125-26-385430.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-385431/0001193125-26-385431.pdf Wed, 09 Sep 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-385431/0001193125-26-385431.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.evommune.com/financial-information/sec-filings/content/0001757283-26-000018/0001757283-26-000018.pdf Fri, 14 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001757283-26-000018/0001757283-26-000018.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://ir.evommune.com/financial-information/sec-filings/content/0000080255-26-000581/0000080255-26-000581.pdf Fri, 14 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0000080255-26-000581/0000080255-26-000581.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-338017/0001193125-26-338017.pdf Thu, 06 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-338017/0001193125-26-338017.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-337984/0001193125-26-337984.pdf Thu, 06 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-337984/0001193125-26-337984.pdf